Inactief instrument

Andere talen Medovex Corp Nasdaq

Aandelen

US58504H1014

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	06/03
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/11
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	10-07-23
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	10-07-23
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22-05-23
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10-05-23
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	10-05-23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18-04-23
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	12-04-23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02-03-23
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	24-02-23
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	29-12-22
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	29-12-22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	28-12-22
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14-11-22
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07-10-22
H-CYTE, Inc. announced that it has received $0.225 million in funding	29-09-22
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days	19-09-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Medovex Corp Nasdaq

Aandelen

US58504H1014

Andere talen

Filters